Athero Review - Issue 2/2016
Editorial Board
Reviews
65
Monoclonal antibodies in the internal medicine
Kristína Brázdilová, Daniel Čierny, Zdenko Killinger, Peter Jackuliak, Juraj Payer
69
Diabetes mellitus and lipid metabolism
Viliam Mojto
74
80
Secondary dislipidemia in renal disease
Jan Vachek, MUDr. PhDr. Oskar Zakiyanov, PhD., Vladimír Tesař
85
Dyslipoproteinemias in endocrinopathies
Zbynek Schroner
88
LDL-cholesterol – the main risk factor for atherosclerosis
Branislav Vohnout, Andrea Havranová
93
Alirocumab, Praluent® in the light of studies
Richard Češka, Lucie Votavová
Athero Review
2016 Číslo 2
Najčítanejšie v tomto čísle
- Monoclonal antibodies in the internal medicine
- Diabetes mellitus and lipid metabolism
- Alirocumab, Praluent® in the light of studies
- LDL-cholesterol – the main risk factor for atherosclerosis